2026 - SNI Inc.

28 Jul 2026

Health Canada Proposes a Streamlined Pathway for Certain Low-Risk Non-Prescription Drugs

DrugsCanadian drug regulations, DIN application Canada, Division 1 drug application, Division 8 new drug, Drug Identification Number Canada, Health Canada drug monographs, Health Canada List D, Health Canada non-prescription drugs, non-prescription drug authorization Canada, over-the-counter drugs Canada

Health Canada is proposing a streamlined authorization pathway for certain low-risk non-prescription drugs in Canada. Eligible List D products that fully comply with an applicable Health Canada monograph could be exempted from Division 8 “new drug” requirements and instead apply for a Drug Identification Number (DIN) under Division 1. The proposal may…

24 Jul 2026

Webinar Recap: Understanding the Organic Certification Process in Canada: What You Need to Know

General RegulationsCanada Organic logo requirements, Canada Organic Regime, Canadian organic standards, organic certification body, organic certification Canada, organic claims Canada, organic food certification, organic product labelling Canada, Organic System Plan Canada

The organic certification process in Canada generally involves reviewing the Canadian organic standards, selecting a certification body, preparing an Organic System Plan, completing an inspection, addressing any non-compliances, and maintaining certification through annual renewal. Source Nutraceutical, Inc. (SNI) recently welcomed the Fraser Valley Organic Producers Association (FVOPA) for a guest…

23 Jul 2026

How Long Does It Take to Get a Natural Product Number (NPN) in Canada?

Natural Health Products (NHPs), NHP RegulationsClass III NPN, health canada, Natural Product Number, NHP licensing, NHP Regulations, NPN application, PLA submission, Regulatory Strategy, Site Licence

Obtaining a Natural Product Number (NPN) in Canada typically takes approximately 60 calendar days for Class I applications, 90 calendar days for Class II applications, and 270 or more calendar days for Class III applications. Due to current review backlogs, companies submitting Class III applications should plan for timelines closer…

21 Jul 2026

Canadian Food Inspection Agency (CFIA) Finalizes Labelling Guidance for Plant-Based Egg Alternatives in Canada

Canadian Food Regulations, Food and BeverageCFIA advertising guidance food labels, CFIA food labelling guidance, egg alternative labelling Canada, false and misleading food labels Canada, plant-based egg alternatives Canada, plant-based egg common name, plant-based food label compliance

CFIA’s guidance explains how plant-based egg alternatives should be labelled and advertised in Canada to avoid misleading consumers. It focuses on clear common names, accurate claims, imagery, packaging, advertising, and the overall impression created by the product. With compliance expected by January 1, 2030, companies should review labels and marketing…

14 Jul 2026

Industry Insight: June 2026 Update: Health Canada Provides Updates on Human Drug Submission Workload Management

Canadian Drug RegulationsCanadian pharmaceuticals, drug submissions, health canada, Health Canada Updates, market access, pharmaceutical regulations, regulatory modernization, Regulatory Strategy, submission backlog

As of June 2026, Health Canada is advancing workload management measures intended to address human drug submission backlogs, improve review predictability, and support more transparent communication with sponsors. These measures include enhanced communication protocols, expanded reliance approaches, HTA alignment, and operational review efficiencies, while maintaining Health Canada’s review standards for…

08 Jul 2026

Industry Insight: June 2026 Update: Health Canada Discusses GMP Inspection Trends, Quality System Expectations, and Compliance Priorities for DEL

Canadian Drug RegulationsCAPA Management, Drug Establishment Licence, Drug Establishment Licensing, Foreign Site Inspections, GMP Inspections Canada, Good Manufacturing Practices, Health Canada compliance, Health Canada GMP, Pharmaceutical Quality Systems

On Tuesday June 23, 2026, at the Pharmaceutical Sciences Group’s (PSG) 9th Annual Day with Health Canada, Karolina Zarichna from Source Nutraceutical, Inc. (SNI) attended discussions on recent Good Manufacturing Practices (GMP) inspection trends and compliance expectations for Canadian and foreign drug establishments. Health Canada provided insight into inspection observations…

30 Jun 2026

Industry Insight: June 2026 Update: Health Canada Discusses the Future of NHP Regulation

Natural Health Products (NHPs), NHP Regulationshealth canada, NHP FPS Requirements, NHP Labelling, NHP licensing, NHP PLA Submission, NHP Update

At the Pharmaceutical Sciences Group’s (PSG) 9th Annual Day with Health Canada Tuesday June 23, 2026, Karolina Zarichna from Source Nutraceutical, Inc. (SNI) attended discussions on the evolving direction of Canada’s Natural Health Product (NHP) regulatory framework. Health Canada highlighted a continued shift toward a more risk-based and proportionate approach to NHP…

24 Jun 2026

What Evidence Do You Need to Substantiate Veterinary Health Product (VHP) Claims in Canada?

Pet Products, Veterinary Health Products (VHPs)

In Canada, Veterinary Health Product (VHP) claims must be supported by objective and credible evidence aligned with the product’s ingredients, conditions of use, and intended purpose. Claims should focus on maintaining or promoting animal health and must not represent the product as treating, diagnosing, mitigating, preventing, or curing disease. Introduction…

17 Jun 2026

Health Canada Updates FPS Expectations for NHP Applications

Natural Health Products (NHPs), NHP RegulationsClass II NHP PLA, Class III NHP PLA, GUI-0158, Health Canada FPS requirements, Natural Health Product licensing Canada, NHP GMP Canada, NHP product licence application, NHP specifications, NNHPD bulletin

As of June 15, 2026, Health Canada no longer expects finished product specifications (FPS) to be submitted upfront with Class II and Class III NHP product licence applications (PLAs) or amendments. However, an FPS must still be established, maintained, and provided to Health Canada upon request. Introduction Health Canada has…

09 Jun 2026

How to Prepare for a Health Canada NHP Site Licence Inspection

NHP Site Licensing

To sell a natural health product (NHP) in Canada, companies must consider both product licensing and site licensing requirements. A product licence authorizes the sale of a specific NHP, while a site licence is required for the Canadian physical site where NHPs are manufactured, packaged, labelled, or imported for sale. Obtaining these licences requires…